Teachers Retirement System of The State of Kentucky lessened its stake in Masimo Co. (NASDAQ:MASI) by 12.9% in the third quarter, HoldingsChannel reports. The institutional investor owned 8,126 shares of the medical equipment provider’s stock after selling 1,200 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Masimo were worth $1,012,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in the business. United Services Automobile Association grew its stake in Masimo by 0.7% in the 2nd quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock worth $6,983,000 after buying an additional 485 shares in the last quarter. US Bancorp DE grew its stake in Masimo by 36.9% in the 2nd quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock worth $193,000 after buying an additional 534 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in Masimo by 3.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock worth $1,819,000 after buying an additional 535 shares in the last quarter. Security Asset Management grew its stake in Masimo by 4.4% in the 3rd quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock worth $1,598,000 after buying an additional 539 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in Masimo by 3.2% in the 3rd quarter. SG Americas Securities LLC now owns 24,081 shares of the medical equipment provider’s stock worth $2,999,000 after buying an additional 756 shares in the last quarter. 88.00% of the stock is owned by institutional investors and hedge funds.
In other news, insider Ramshorst David J. Van sold 1,325 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $125.00, for a total value of $165,625.00. Following the completion of the sale, the insider now directly owns 2,325 shares in the company, valued at approximately $290,625. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Joe E. Kiani sold 239,926 shares of the business’s stock in a transaction that occurred on Tuesday, September 4th. The stock was sold at an average price of $117.95, for a total transaction of $28,299,271.70. Following the completion of the sale, the chief executive officer now owns 236,061 shares of the company’s stock, valued at $27,843,394.95. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 569,106 shares of company stock valued at $68,242,221. Company insiders own 12.60% of the company’s stock.
Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.69 by $0.02. The firm had revenue of $210.58 million during the quarter, compared to analyst estimates of $207.62 million. Masimo had a net margin of 17.08% and a return on equity of 20.29%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.56 EPS. On average, research analysts predict that Masimo Co. will post 2.92 earnings per share for the current year.
A number of equities analysts have commented on MASI shares. Stifel Nicolaus boosted their price target on shares of Masimo from $112.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 2nd. BidaskClub lowered shares of Masimo from a “buy” rating to a “hold” rating in a report on Tuesday, November 13th. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a report on Tuesday, November 27th. Piper Jaffray Companies boosted their price objective on shares of Masimo to $120.00 and gave the stock a “neutral” rating in a report on Thursday, November 1st. Finally, UBS Group started coverage on shares of Masimo in a report on Tuesday, November 27th. They issued a “buy” rating and a $137.00 price objective for the company. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Masimo currently has a consensus rating of “Buy” and an average target price of $119.00.
COPYRIGHT VIOLATION WARNING: This piece was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2018/12/02/teachers-retirement-system-of-the-state-of-kentucky-cuts-holdings-in-masimo-co-masi.html.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
See Also: Ex-Dividend
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.